D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 84 Citations 32,802 314 World Ranking 9859 National Ranking 930

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • World War II

Michel P Coleman mostly deals with Cancer, Demography, Relative survival, Breast cancer and Survival rate. His study on Cancer is covered under Internal medicine. His research in Demography intersects with topics in Epidemiology, Young adult, Gerontology, Colorectal cancer and Survival analysis.

His Survival analysis study integrates concerns from other disciplines, such as Global health and Socioeconomic status. His biological study spans a wide range of topics, including Liver cancer, Prostate cancer, Public health and Cancer survival. The various areas that Michel P Coleman examines in his Breast cancer study include Cervical cancer and Oncology.

His most cited work include:

  • Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) (1225 citations)
  • Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study (1157 citations)
  • Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. (1120 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Cancer, Demography, Internal medicine, Relative survival and Survival analysis. His research integrates issues of Surgery, Epidemiology and Incidence in his study of Cancer. Within one scientific family, Michel P Coleman focuses on topics pertaining to Breast cancer under Demography, and may sometimes address concerns connected to Cervical cancer and Lung cancer.

Michel P Coleman has researched Internal medicine in several fields, including Gynecology and Oncology. His research in Relative survival tackles topics such as Cancer survival which are related to areas like Socioeconomic inequalities. He has included themes like Social class and Adenocarcinoma in his Survival analysis study.

He most often published in these fields:

  • Cancer (48.87%)
  • Demography (32.48%)
  • Internal medicine (23.15%)

What were the highlights of his more recent work (between 2014-2021)?

  • Cancer (48.87%)
  • Demography (32.48%)
  • Cancer registry (13.83%)

In recent papers he was focusing on the following fields of study:

Cancer, Demography, Cancer registry, Internal medicine and Cancer survival are his primary areas of study. Breast cancer and Colorectal cancer are the core of his Cancer study. His Demography research incorporates elements of Public health surveillance, Public health, Net Survival and Relative survival.

His Relative survival research incorporates themes from Liver cancer and Survival rate, Surgery. His study in Cancer registry is interdisciplinary in nature, drawing from both Medical record, Family medicine, Data quality, International comparisons and Survival analysis. His research investigates the connection between Internal medicine and topics such as Oncology that intersect with issues in Ovarian cancer and Pathology.

Between 2014 and 2021, his most popular works were:

  • Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) (1225 citations)
  • Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. (1120 citations)
  • Cancer survival in China, 2003–2005: A population‐based study (339 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • World War II

Michel P Coleman mainly focuses on Cancer, Demography, Cancer registry, Survival analysis and Breast cancer. His Cancer research is multidisciplinary, incorporating perspectives in Incidence, Oncology, Young adult, Public health and Pediatrics. His Demography study combines topics from a wide range of disciplines, such as Liver cancer, Relative survival, Lung cancer and Gerontology.

The study incorporates disciplines such as Survival rate, Surgery, Rural area, Esophageal cancer and Cancer prevention in addition to Relative survival. His work carried out in the field of Cancer registry brings together such families of science as Clinical trial, Health care, Cancer staging, Mortality rate and Data quality. Michel P Coleman focuses mostly in the field of Breast cancer, narrowing it down to topics relating to Cervical cancer and, in certain cases, Skin cancer, Global health, Gynecology and Colorectal cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Claudia Allemani;Tomohiro Matsuda;Veronica Di Carlo;Rhea Harewood.
The Lancet (2018)

2891 Citations

Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

Claudia Allemani;Hannah K Weir;Helena Carreira;Rhea Harewood.
The Lancet (2015)

2432 Citations

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study

Roberta De Angelis;Milena Sant;Michel P Coleman;Silvia Francisci.
Lancet Oncology (2014)

2120 Citations

Cancer survival in five continents: a worldwide population-based study (CONCORD)

Michel P. Coleman;Manuela Quaresma;Franco Berrino;Jean Michel Lutz.
Lancet Oncology (2008)

1642 Citations

An international association between Helicobacter pylori infection and gastric cancer

D Forman;M Coleman;Gui De Backer;J Eider.
The Lancet (1993)

1400 Citations

Trends in cancer incidence and mortality

M P Coleman;J Estève;P Damiecki;A Arslan.
IARC scientific publications (1993)

1331 Citations

Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

MP Coleman;D Forman;H Bryant;J Butler.
The Lancet (2011)

938 Citations

Origins of socio-economic inequalities in cancer survival: a review

L. M. Woods;B. Rachet;M. P. Coleman.
Annals of Oncology (2006)

709 Citations

The global burden of women's cancers: a grand challenge in global health

Ophira M Ginsburg;Ophira M Ginsburg;Freddie Bray;Michel P Coleman;Verna Dnk Vanderpuye.
The Lancet (2017)

707 Citations

Cancer survival in China, 2003–2005: A population‐based study

Hongmei Zeng;Rongshou Zheng;Yuming Guo;Siwei Zhang.
International Journal of Cancer (2015)

706 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Michel P Coleman

Hermann Brenner

Hermann Brenner

German Cancer Research Center

Publications: 134

Freddie Bray

Freddie Bray

International Agency For Research On Cancer

Publications: 100

Henrik Møller

Henrik Møller

King's College London

Publications: 79

Paul C. Lambert

Paul C. Lambert

University of Leicester

Publications: 70

David Forman

David Forman

International Agency For Research On Cancer

Publications: 61

Jan Willem Coebergh

Jan Willem Coebergh

Erasmus University Rotterdam

Publications: 58

Paolo Boffetta

Paolo Boffetta

Stony Brook Medicine

Publications: 55

Timo Hakulinen

Timo Hakulinen

University of Helsinki

Publications: 55

Joanne F. Aitken

Joanne F. Aitken

Cancer Council Queensland

Publications: 54

Hans H. Storm

Hans H. Storm

National Institutes of Health

Publications: 53

Jean Faivre

Jean Faivre

University of Franche-Comté

Publications: 48

Kari Hemminki

Kari Hemminki

Charles University

Publications: 45

Franco Berrino

Franco Berrino

Istituto Superiore di Sanità

Publications: 44

Marilyn Stovall

Marilyn Stovall

The University of Texas MD Anderson Cancer Center

Publications: 40

Carlo La Vecchia

Carlo La Vecchia

University of Milan

Publications: 39

Charles A. Stiller

Charles A. Stiller

Public Health England

Publications: 38

Trending Scientists

Sophia Ananiadou

Sophia Ananiadou

University of Manchester

Shlomo Engelson Argamon

Shlomo Engelson Argamon

Illinois Institute of Technology

Lance Eliot Brouthers

Lance Eliot Brouthers

Kennesaw State University

Stefanie Reese

Stefanie Reese

RWTH Aachen University

Eric Michielssen

Eric Michielssen

University of Michigan–Ann Arbor

Avraham A. Levy

Avraham A. Levy

Weizmann Institute of Science

Michael N. Weedon

Michael N. Weedon

University of Exeter

Tore Slagsvold

Tore Slagsvold

University of Oslo

William L. Ogren

William L. Ogren

United States Department of Agriculture

Michael Levitt

Michael Levitt

Stanford University

Christophe Vigny

Christophe Vigny

École Normale Supérieure

Andrew Steele

Andrew Steele

Carnegie Institution for Science

Yujie Wang

Yujie Wang

University of Maryland, Baltimore County

Lars K. Poulsen

Lars K. Poulsen

Copenhagen University Hospital

Sander van der Linden

Sander van der Linden

University of Cambridge

Sharmila Majumdar

Sharmila Majumdar

University of California, San Francisco

Something went wrong. Please try again later.